#MRK
3 articles tagged "MRK".
Company Snapshot
Merck (MRK): What This Company Actually Does
A plain-English read of Merck's business — the cancer immunotherapy Keytruda that alone drives nearly half of company revenue, plus vaccines and animal health — built directly from its SEC filings.
2026-09-12The StoryMerck's Story: How an '$11 Billion by 2030' Promise Quietly Disappeared
For nearly three years, Merck insisted nothing had changed about Gardasil's $11 billion 2030 target. Then a Chinese distributor's inventory glut forced a formal withdrawal — in a single earnings call.
2026-09-12Reverse DCFWhat MRK's Stock Price Is Really Betting On
Reverse-engineering the free-cash-flow growth rate Merck's share price already assumes — and finding a moderately aggressive ask that has to hold up right through Keytruda's 2028 patent cliff.
2026-09-12